D-1067-2013 Class III Terminated
FDA drug recall D-1067-2013 was initiated by Osmotica Pharmaceutical Corp on Sep 16, 2013 and is designated Class III. Reason for recall: Failed Dissolution Specification:12 hour time point at 18 months of product shelf life. The recall status is terminated (terminated May 9, 2014). Affected quantity: 57857 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 9, 2013
- Initiation Date
- Sep 16, 2013
- Termination Date
- May 9, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 57857 bottles
Product description
Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268-32) and b) 90-count bottle (NDC: 0131-3268-46), Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. For: Osmotica Pharmaceutical Corp., Wilmington, NC 28405, USA.
Reason for recall
Failed Dissolution Specification:12 hour time point at 18 months of product shelf life.
Distribution pattern
Nationwide
Code information
Lot #: a) 58975, 58976, 58977, 65165 , Exp 01/14; b) 58973, 58974, 65131, Exp: 01/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1067-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026